[EN] NEW NAPHTHO[2,3-B]FURAN DERIVATIVES<br/>[FR] NOUVEAUX DÉRIVÉS DE NAPHTHO[2,3-B]FURANE
申请人:BAN HITOSHI
公开号:WO2018096401A1
公开(公告)日:2018-05-31
The present invention provides a compound useful as a novel antitumor agent targeting a CSC that is important in continuous proliferation of malignant tumor, metastasis and recurrence of cancer, and its resistance to an antitumor agent; a medicament comprising the compound as an active ingredient; a pharmaceutical composition; and an antitumor agent; as well as a method of treating cancer and/or a method of preventing cancer. The present invention provides compounds represented by formula (I) : or pharmaceutically acceptable salts thereof, wherein X is an oxygen atom or sulfur atom; R1 is a hydrogen atom, an alkyl group, or the like; R2 is a halogen atom or the like; R3 is a hydrogen atom, an alkyl group, or the like; m is 0, 1, 2, 3, or 4; and n is 1, 2, 3, or 4 (with the proviso that the sum of m and n is 1, 2, 3, or 4).
本发明提供了一种化合物,作为一种新型抗肿瘤剂,针对在恶性肿瘤的持续增殖、转移和复发以及其对抗肿瘤药物的耐药性中起重要作用的CSC;一种以该化合物作为活性成分的药物;一种制药组合物;一种抗肿瘤剂;以及治疗癌症和/或预防癌症的方法。本发明提供了由式(I)表示的化合物或其药学上可接受的盐,其中X是氧原子或硫原子;R1是氢原子、烷基或类似物;R2是卤原子或类似物;R3是氢原子、烷基或类似物;m是0、1、2、3或4;n是1、2、3或4(前提是m和n的总和为1、2、3或4)。